Hospitalization for skin disease improves quality of life.
- 1 June 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 133 (6) , 797-798
- https://doi.org/10.1001/archderm.1997.03890420143028
Abstract
Inpatient dermatologic services are diminishing. A recent survey1of dermatology residents reports that 17% do not care for hospitalized patients and that less than 1% of residents care for 60 or more hospitalized patients per month. One reason for this decrease is the increasing pressure to contain medical costs. Stringent guidelines have been set up for hospital admission, length of stay, and intensity of care, all encompassed in a specific diagnostic related group that represents a certain sum for a given diagnosis. Despite these firm criteria, few objective tests are used routinely to assess the outcome, effectiveness, or cost of dermatologic hospitalization. One outcome measure is the Psoriasis Area and Severity Index, which is often used to quantify the effectiveness of treatments for psoriasis.2In addition, a patient-oriented measure of outcome, the Dermatology Life Quality Index, and other depression and anxiety tests can be used to measure objectivelyKeywords
This publication has 3 references indexed in Scilit:
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationPublished by Elsevier ,2002
- The outcomes movement and new measures of the severity of psoriasisJournal of the American Academy of Dermatology, 1996
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994